RFA-MH-26-120-Full-Announcement.html

This document is a Request for Applications (RFA) for the BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed) funding opportunity. The RFA is issued by the National Institutes of Health (NIH) and is intended to support the establishment of facilities at minority-serving institutions (MSIs) and Institutional Development Award (IDeA)-eligible institutions for the scaled production and distribution of brain cell type-specific access and manipulation reagents. The reagents will initially be developed through the BRAIN Initiative Armamentarium project and will enable neuroscientists to probe circuit function with high precision in experimental animals and ex vivo human tissue and cells. Eligible applicant types include tribal governments, nonprofits, higher education institutions, small businesses, and other organizations. The funding instrument is a cooperative agreement, and the award period is expected to be 5 years. This RFA is assigned to multiple NIH grant programs, including Mental Health Research Grants, Alcohol Research Programs, and Drug Use and Addiction Research Programs, among others.